Synaptic protein CSF levels relate to memory scores in individuals without dementia

Synaptic protein CSF levels relate to memory scores in individuals without dementia

Background: We investigated how cerebrospinal fluid levels of synaptic proteins associate with memory function in normal cognition (CN) and mild cognitive impairment (MCI), and investigated the effect of amyloid positivity on these associations. Methods: We included 242 CN (105(43%) abnormal amyloid...

Szczegółowa specyfikacja

Opis bibliograficzny
Główni autorzy:	Wesenhagen, KEJ, de Leeuw, DM, Tomassen, J, Gobom, J, Bos, I, Vos, SJB, Martinez-Lage, P, Tainta, M, Popp, J, Peyratout, G, Tsolaki, M, Vandenberghe, R, Freund-Levi, Y, Verhey, F, Lovestone, S, Streffer, J, Dobricic, V, Blennow, K, Scheltens, P, Smit, AB, Bertram, L, Teunissen, CE, Zetterberg, H, Tijms, BM
Format:	Journal article
Język:	English
Wydane:	BioMed Central 2025

Podobne zapisy

CSF proteomic profiles of neurodegeneration biomarkers in Alzheimer's disease
od: Delvenne, A, i wsp.
Wydane: (2024)

Involvement of the choroid plexus in Alzheimer’s disease pathophysiology: findings from mouse and human proteomic studies
od: Delvenne, A, i wsp.
Wydane: (2024)

White paper by the Society for CSF Analysis and Clinical Neurochemistry: Overcoming barriers in biomarker development and clinical translation
od: Teunissen, C, i wsp.
Wydane: (2018)

Validation of plasma proteomic biomarkers relating to brain amyloid burden in the EMIF-Alzheimer's disease multimodal biomarker discovery cohort
od: Westwood, S, i wsp.
Wydane: (2020)

MRI predictors of amyloid pathology: results from the EMIF-AD multimodal biomarker discovery study
od: ten Kate, M, i wsp.
Wydane: (2018)

Inflammatory biomarkers in Alzheimer's disease plasma
od: Morgan, A, i wsp.
Wydane: (2019)

Discovery and validation of plasma proteomic biomarkers relating to brain amyloid burden by SOMAscan assay
od: Shi, L, i wsp.
Wydane: (2019)

The influence of insulin resistance on CSF and plasma biomarkers of Alzheimer’s pathology
od: Westwood, S, i wsp.
Wydane: (2017)

ISOLATION OF YACS FOR CSF-1R AND CSF-1 AND GENE LOCALIZATION USING FISH
od: Boultwood, J, i wsp.
Wydane: (1992)

Plasma protein biomarkers for the prediction of CSF amyloid and tau and [18F]-flutemetamol PET scan result
od: Westwood, S, i wsp.
Wydane: (2018)

Diagnostic value of cerebrospinal fluid neurofilament light protein in neurology: A systematic review and meta-analysis
od: Bridel, C, i wsp.
Wydane: (2019)

CSF ELECTROPHORESIS IN 1000 PATIENTS
od: Ebers, G
Wydane: (1980)

Prognostic value of CSF lactate in cerebral malaria.
od: White, N, i wsp.
Wydane: (1987)

SIGNIFICANCE OF THE SINGLE BAND IN CSF PROTEIN ELECTROPHORESIS
od: Bass, B, i wsp.
Wydane: (1986)

Response to treatment with TNFα inhibitors in rheumatoid arthritis is associated with high levels of GM-CSF and GM-CSF(+) T lymphocytes
od: Bystrom, J, i wsp.
Wydane: (2017)

Inflammation-related plasma and CSF biomarkers for multiple sclerosis
od: Huang, J, i wsp.
Wydane: (2020)

CSF electrophoresis in one thousand patients.
od: Ebers, G, i wsp.
Wydane: (1980)

CNS barriers and modern CSF diagnostics /
od: Felgenhauer, Klaus, i wsp.
Wydane: (1993)

Interpretation of single band patterns in CSF protein electrophoresis.
od: Bass, B, i wsp.
Wydane: (1988)

Multicenter validation of CSF neurofilaments as diagnostic biomarkers for ALS
od: Oeckl, P, i wsp.
Wydane: (2016)

CNS infection, CSF matrix metalloproteinase concentrations, and clinical/laboratory features.
od: Green, J, i wsp.
Wydane: (2011)

Identification of N-glycosylation changes in the CSF and serum in patients with schizophrenia.
od: Stanta, J, i wsp.
Wydane: (2010)

A study of CSF idiotypes in multiple sclerosis.
od: Ebers, G
Wydane: (1982)

Decreased CSF acetylcholinesterase activity in Alzheimer's disease.
od: Appleyard, M, i wsp.
Wydane: (1983)

CSF chitinase proteins in amyotrophic lateral sclerosis
od: Thompson, A, i wsp.
Wydane: (2019)

Determination of CSF GFAP, CCN5, and vWF levels enhances the diagnostic accuracy of clinically defined MS from non-MS patients with CSF oligoclonal bands
od: Probert, F, i wsp.
Wydane: (2022)

CSF chitinases before and after symptom onset in amyotrophic lateral sclerosis
od: Gray, E, i wsp.
Wydane: (2020)

Identification of a possible proteomic biomarker in Parkinson’s disease: discovery and replication in blood, brain and CSF
od: Winchester, L, i wsp.
Wydane: (2022)

RANKL and M-CSF are required for osteoclast differentiation by macrophages in breast cancer
od: Danks, L, i wsp.
Wydane: (2003)

Cerebrospinal fluid biomarkers of neurodegeneration, synaptic integrity, and astroglial activation across the clinical Alzheimer's disease spectrum
od: Bos, I, i wsp.
Wydane: (2019)

Gene expression profiling of day 7 erythroblasts from refractory anemia with ringed sideroblasts (RARS) and microarray-based identification of erythroid granulocyte-CSF (G-CSF) targets
od: Nikpour, M, i wsp.
Wydane: (2009)

Is Normal Pressure Hydrocephalus more than a mechanical disruption to CSF flow?
od: Tully, B, i wsp.
Wydane: (2010)

Is Normal Pressure Hydrocephalus more than a mechanical disruption to CSF flow?
od: Tully, B, i wsp.
Wydane: (2010)

Is Normal Pressure Hydrocephalus more than a mechanical disruption to CSF flow?
od: Tully, B, i wsp.
Wydane: (2010)

Alpha-synuclein RT-QuIC in the CSF of patients with alpha-synucleinopathies
od: Parkkinen, L, i wsp.
Wydane: (2016)

UFLC-derived CSF extracellular vesicle origin and proteome
od: Thompson, A, i wsp.
Wydane: (2018)

Myelin oligodendrocyte glycoprotein CSF testing needs testing
od: Waters, P, i wsp.
Wydane: (2019)

CSF1R inhibitor JNJ-40346527 attenuates microglial proliferation and neurodegeneration in P301S mice
od: Mancuso, R, i wsp.
Wydane: (2019)

Neurofilament heavy chain in CSF correlates with relapses and disability in multiple sclerosis.
od: Kuhle, J, i wsp.
Wydane: (2011)

Functional changes in CSF volume estimated using measurement of water T2 relaxation.
od: Piechnik, S, i wsp.
Wydane: (2009)